基于APRI+ALBI的多变量模型作为肝切除术后肝衰竭的术前预测工具
本研究利用美国国家外科质量改进计划数据库12056例患者构建基于APRI+ALBI的多变量模型预测临床显著肝切除术后肝衰竭(PHLF B+C),模型包含APRI+ALBI、年龄、性别、肿瘤类型和切除范围,在验证队列2525例中AUC为0.74,与基于ICG清除率或ALICE的模型预测效能相当,并开发了免费智能手机应用。
要点
- APRI+ALBI多变量模型预测PHLF B+C的AUC为0.77,验证队列AUC为0.74。
- 与基于ICG清除率或ALICE的模型相比,APRI+ALBI模型预测PHLF B+C的效能相当。
- 该模型基于常规实验室指标,成本低且普遍可用,并配有免费智能手机应用。
核心结论
- 基于APRI+ALBI的多变量模型可提高PHLF B+C的术前预测准确性,是一种普遍可用且成本效益好的肝切除术前风险评估工具,并可通过免费智能手机应用计算。
研究设计与样本
- 利用美国国家外科质量改进计划数据库12056例患者构建预测PHLF B+C的多变量模型,采用逐步向后消除法确定模型,并在国际队列2525例患者中验证;在620例患者中比较APRI+ALBI模型与基于ICG清除率或ALICE的模型的AUC。
主要发现
- 包含APRI+ALBI、年龄、性别、肿瘤类型和切除范围的多变量模型预测PHLF B+C的AUC为0.77,验证队列AUC为0.74。
- 在620例患者中,APRI+ALBI模型与基于ICG清除率或ALICE的模型对PHLF B+C的预测效能相当。
关键数值与推荐
- APRI+ALBI多变量模型预测PHLF B+C的AUC为0.77,验证队列AUC为0.74。
- 与基于ICG清除率或ALICE的模型直接比较,APRI+ALBI模型对PHLF B+C的预测潜能相当。
临床怎么用
- 原文结论认为基于APRI+ALBI的多变量模型可提高PHLF B+C的术前预测准确性,是一种普遍可用且成本效益好的术前风险评估工具,并配有免费智能手机应用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE AND BACKGROUND: Clinically significant posthepatectomy liver failure (PHLF B+C) remains the main cause of mortality after major hepatic resection. This study aimed to establish an aspartate aminotransferase to platelet ratio combined with an albumin-bilirubin grade (APRI+ALBI), based multivariable model (MVM) to predict PHLF and compare its performance to indocyanine green clearance (ICG-R15 or ICG-PDR) and albumin-ICG evaluation (ALICE). METHODS: A total of 12,056 patients from the National Surgical Quality Improvement Program database were used to generate a MVM to predict PHLF B+C. The model was determined using stepwise backwards elimination. The performance of the model was tested using receiver operating characteristic curve analysis and validated in an international cohort of 2525 patients. In 620 patients, the APRI+ALBI MVM, trained in the National Surgical Quality Improvement Program cohort, was compared with the MVM's based on other liver function tests (ICG clearance, ALICE) by comparing the areas under the curve (AUC). RESULTS: A MVM including APRI+ALBI, age, sex, tumor type, and extent of resection was found to predict PHLF B+C with an AUC of 0.77, with comparable performance in the validation cohort (AUC: 0.74). In direct comparison with other MVM's based on more expensive and time-consuming liver function tests (ICG clearance, ALICE), the APRI+ALBI MVM demonstrated equal predictive potential for PHLF B+C. A smartphone application for the calculation of the APRI+ALBI MVM was designed. CONCLUSION: Risk assessment through the APRI+ALBI MVM for PHLF B+C increases preoperative predictive accuracy and represents a universally available and cost-effective risk assessment before hepatectomy, facilitated by a freely available smartphone app.
引用
- Santol J, Kim S, Gregory LA, et al. An APRI+ALBI-Based Multivariable Model as a Preoperative Predictor for Posthepatectomy Liver Failure. Ann Surg. 2023. PMID: 37860868. doi:10.1097/SLA.0000000000006127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。